Governance Eli Lilly and Company

LLY

US5324571083

Pharmaceuticals

Market Closed - NYSE Other stock markets 04:03:04 2026-07-13 pm EDT			Pre-market 08:00:00 pm
1,181.87 ^USD	-0.56%		1,166.25	-1.32%

Jul. 13	FDA approves at-home starter dose of Eisai-Biogen Alzheimer's drug	RE
Jul. 13	UBS Adjusts Eli Lilly Price Target to $1,425 From $1,250, Maintains Buy Rating	MT

Executive Committee: Eli Lilly and Company

Manager

Positions heldSince

David Ricks

58 year

Chief Executive Officer	2016-12-31
President	2016-12-31

Eric Dozier

59 year

Human Resources Officer

2022-08-30

David Hyman

Chief Tech/Sci/R&D Officer

2023-10-15

Thomas Fuchs

47 year

Chief Tech/Sci/R&D Officer

2024-10-20

Diogo Rau

51 year

Chief Tech/Sci/R&D Officer

2021-05-16

Lucas Montarce

49 year

Director of Finance/CFO

2024-09-08

Donald Zakrowski

Comptroller/Controller/Auditor

2012-10-31

Daniel Skovronsky

52 year

Chief Tech/Sci/R&D Officer

Anat Hakim

56 year

General Counsel	2020-02-02
Corporate Secretary	-

Michael Czapar

42 year

Investor Relations Contact

2024-06-30

Composition of the Board of Directors: Eli Lilly and Company

Director

CommitteesSince

David Ricks

58 year

Compensation Committee

2018-04-11

Ralph Alvarez

70 year

Audit Committee
Compensation Committee Chair
Compensation Committee
Governance Committee
Nominating Committee

Carolyn Bertozzi

59 year

Governance Committee
Nominating Committee
Compensation Committee
HR Committee

Gabrielle Greene-Sulzberger

65 year

Audit Committee	2021-01-24
Governance Committee
Nominating Committee	2018-11-30

Jamere Jackson

56 year

Governance Committee	2016-09-30
Audit Committee Chair	2016-09-30

William Kaelin

68 year

Governance Committee	2025-11-04
Nominating Committee	2025-11-04

Mary Lynne Hedley

63 year

Governance Committee Chair	2019-08-15
Nominating Committee Chair	2019-08-15

Juan Luciano

64 year

Compensation Committee
Governance Committee Chair

Jon Moeller

62 year

Audit Committee	2024-11-30
Governance Committee	2024-11-30

Kimberly Johnson

53 year

Compensation Committee

2021-02-15

Jon Fyrwald

66 year

Compensation Committee

Katherine Baicker

54 year

Director/Board Member	2011-12-11
Independent Dir/Board Member	2011-12-11

Latest Appointments: Eli Lilly and Company

Jun. 24	Global markets live: Qualcomm, Apple, SK Hynix, Eli Lilly, FedEx, Nike…
Jun. 23	Trimtech Therapeutics Limited announced that it has received £35.6 million in funding from a group of investors	CI
Apr. 28	Sekar Kathiresan Not Stands for Re-Election as a Class III Director of Relay Therapeutics, Inc	CI
Apr. 23	Vaxart, Inc. Appoints James Breitmeyer, M.D., Ph.D., to Board of Directors	CI
Apr. 20	Neurogene Inc. Announces Executive and Board Appointments	CI
Apr. 17	Alterity Therapeutics Limited Appoints Ann Cunningham as Independent Non-Executive Director, Effective April 17, 2026	CI
Apr. 08	Incyclix Bio, LLC announced that it has received $46.25 million in funding from a group of investors	CI

More news

Former Officers and Directors: Eli Lilly and Company

Insider

Positions held

SinceUntil

Kathi P. Seifert

Director/Board Member	1994-12-31	2021-05-02
Independent Dir/Board Member	1994-12-31	2021-05-02

Ellen Marram

Director/Board Member	2001-12-31	2019-04-30
Chairman	2013-05-08	2013-07-07
Independent Dir/Board Member	2011-12-31	2019-04-30

John Lechleiter

Director/Board Member	2004-12-31	2008-12-31
Chief Executive Officer	2008-03-31	2016-12-30
Chairman	2008-12-31	2017-05-30
Chief Operating Officer	2004-12-31	2008-03-31
General Counsel	1993-12-31	1997-12-31
Corporate Officer/Principal	1997-12-31	2004-12-31
President	2004-12-31	2016-12-30

Derica Rice

Comptroller/Controller/Auditor	2002-12-31	2005-12-31
Director of Finance/CFO	2005-12-31	2016-12-31

Franklyn Prendergast

Director/Board Member	1995-03-31	2016-12-31
Independent Dir/Board Member	1995-03-31	2016-12-31

Karen Horn

Director/Board Member	1986-12-31	2016-05-01
Independent Dir/Board Member	2011-04-14	2016-05-01

Win Bischoff

Director/Board Member	2000-03-31	2014-05-04
Independent Dir/Board Member	2011-04-24	2014-05-04

Robert A. Armitage

Director/Board Member	2011-04-25	2011-05-04
General Counsel	1999-10-31	2012-12-30

Arnold Hanish

Comptroller/Controller/Auditor

1983-12-31

2012-11-30

Martin Feldstein

Director/Board Member	2001-12-31	2012-06-03
Independent Dir/Board Member	2011-04-14	2012-06-03

Frank M. Deane

Director/Board Member	2011-05-04	2011-05-05
Corporate Officer/Principal	1985-12-31	2011-12-31

Anne Nobles

Director/Board Member	2011-05-04	2011-09-06
General Counsel	1989-12-31	2011-12-31

Alex Azar

Public Communications Contact	2007-05-31	2009-03-31
Corporate Officer/Principal	2009-03-31	2011-11-30

David Bredt

Corporate Officer/Principal

2003-12-31

2010-12-31

Gino Santini

Corporate Officer/Principal

1989-12-31

2010-11-30

Steven Paul

Chief Tech/Sci/R&D Officer

1993-03-31

2010-01-31

Anthony John Murphy

Human Resources Officer

1979-12-31

2009-04-29

J. Cook

Director/Board Member

2004-12-31

2009-04-19

Deirdre Connelly

Human Resources Officer	2002-12-31	2005-05-31
Corporate Officer/Principal	2005-05-31	2009-01-29

Charles Golden

Director of Finance/CFO

1996-02-29

2006-04-29

John Edward Victor Rose

Director/Board Member

2005-10-13

Steven C. Beering

Director/Board Member

2005-04-17

Bryan Dunnivant

Chief Operating Officer

2000-12-31

2004-12-30

Vanessah Ng

Corporate Officer/Principal

2004-12-30

Webster Dunbar

Chief Tech/Sci/R&D Officer	1998-12-31	2002-12-31
Corporate Officer/Principal	2002-12-31	2004-08-31

Joseph Zakrzewski

Corporate Officer/Principal

2002-12-31

2003-12-31

Pedro Granadillo

Human Resources Officer	1969-12-31	2003-12-31
Corporate Officer/Principal	1969-12-31	2003-12-31

Scott Priebe

Corporate Officer/Principal

2003-12-30

Alan Breier

Chief Tech/Sci/R&D Officer

2003-07-31

August M. Watanabe

Corporate Officer/Principal

2003-05-31

Brett L. Schmidli

Corporate Officer/Principal

1991-12-31

2001-12-31

Jerome H. Fleisch

Corporate Officer/Principal

1973-12-31

2001-12-30

Stephen W. Kaldor

Corporate Officer/Principal

1989-05-31

2001-12-30

David A. Broecker

Corporate Officer/Principal

1985-07-31

2000-12-31

George Fisher

Director/Board Member

1999-12-31

John T. Boris

Corporate Officer/Principal

1988-01-01

1997-12-31

Lionel Carnot

Corporate Officer/Principal

1994-12-31

1996-12-31

Paul F. Banta

General Counsel

1987-05-31

1994-12-31

Alfred G. Gilman

Director/Board Member	1994-12-31	-
Independent Dir/Board Member	2011-04-14	-

James Cornelius

Director/Board Member	1982-12-31	1994-12-31
Director of Finance/CFO	1982-12-31	1994-12-31

Ron Henriksen

Corporate Officer/Principal

1970-12-31

1993-12-31

B. Jack Miller

Human Resources Officer

1967-12-31

1987-12-30

James F. White

Corporate Officer/Principal

Mike Peterson

Corporate Officer/Principal

Simon Li

Corporate Officer/Principal

Rafik H. Bishara

Corporate Officer/Principal

Michael Heffernan

Corporate Officer/Principal

Michael Sherman

Corporate Officer/Principal

Seth D. Goldblum

Corporate Officer/Principal

Erin Markey

Corporate Officer/Principal

Stephen Andrade

Corporate Officer/Principal

Molly Montgomery

Corporate Officer/Principal

Jack Steele

Corporate Officer/Principal

Eric E. Easom

Corporate Officer/Principal

Pat O'Day

Corporate Officer/Principal

Paul A. Hyslop

Corporate Officer/Principal

Dennis W. White

Corporate Officer/Principal

Stephen E. Butts

Corporate Officer/Principal

Ronald A. Matricaria

Corporate Officer/Principal

Robert W. McLaughlin

Corporate Officer/Principal

Wei Zhang

Corporate Officer/Principal

Todd F. Kirschner

Corporate Officer/Principal

Aaron Davidson

Corporate Officer/Principal

John R. Uhrin

Corporate Officer/Principal

Jim R. Baumgardt

Director/Board Member

James B. Lootens

Corporate Secretary

John Barnard

Corporate Officer/Principal

Donald C. Aroborgast

Corporate Officer/Principal

Anton G. Gueth

Corporate Officer/Principal

William D. Huse

Corporate Officer/Principal

Chen-Ming Yu

Corporate Officer/Principal

Kurt Wheeler

Corporate Officer/Principal

Fredric Cohen

Corporate Officer/Principal

Dale M. Edgar

Director/Board Member

Edward S. Dunn

Corporate Officer/Principal

Vincent J. Gurnari

Sales & Marketing

P. Reed Maurer

Corporate Officer/Principal

Age distribution of managers

Parity Men Women

Male	31
Female	9

Of which Executive Committee

Male	9
Female	1

Of which Directors

Male	10
Female	2

Revisions

Recommandations analystes

Évolution recommandations analystes 1 an

Évolution recommandations analystes 4 mois

Objectif analystes

Évolution objectif analystes 1 an

Évolution objectif analystes 4 mois

ESG MSCI

Environnement

Social

Gouvernance

Polémique

Controverses Ethiques

Yes

Controverses sur les droits de l'Homme

Controverses Subventions fiscales

Conforme à la finance Islamique

Eli Lilly and Company is one of the world's leading pharmaceutical groups. Net sales break down by therapeutic field as follows: - endocrinology (74%): products for treating osteoporosis, diabetes, and growth problems; - oncology (14.4%); - immunology diseases (8.1%); - neurology (2.1%): primarily drugs used in treating depression and schizophrenia; - other (1.4%). Net sales are distributed geographically as follows: the United States (66.7%), Europe (17.7%), Japan (3.2%), China (3%) and other (9.4%).

Employees

50,000

Sector

Pharmaceuticals

Calendar

Earnings release - Q2 2026

More about the company